Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DEFERASIROX GRANULES safely and effectively. See full prescribing information for DEFERASIROX GRANULES .<BR><BR>DEFERASIROX granules, for oral use<BR>Initial U.S. Approval:2005
Medication labelWhy this: Advisory · dailymed-prescription
Deferasirox granules are indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older. Deferasirox granules are indicated for the treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) syndromes and with a liver iron concentration (LIC) of at least 5 milligrams of iron per gram of liver dry weight (mg Fe/g dw) and a serum ferritin greater than 300 mcg/L. The safety and efficacy of deferasirox when administered with other iron chelation therapy have not been established.
- generic_name
- deferasirox
- product_names
- Deferasirox
- ndc
- 69097-550, 69097-560, 69097-570, 69097-550-53, 69097-560-53, 69097-570-53
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en